This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of quinolone antibiotics. Its structural features, including the cyclopropyl group and difluoromethoxy moiety, contribute to the enhanced antibacterial activity of the final drug products. It is particularly valuable in the development of broad-spectrum antibiotics that target both Gram-positive and Gram-negative bacteria. The ethyl ester group in the molecule aids in improving the compound's solubility and bioavailability during the drug formulation process. Researchers also explore its potential in modifying pharmacokinetic properties, such as absorption and distribution, to optimize therapeutic efficacy. Additionally, it serves as a building block in medicinal chemistry for designing novel antimicrobial agents with improved resistance profiles.